We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
AXP | AXP Energy Limited | 0.002 | 0.001 | 100.00% | 45,000 | 2 |
TMKOB | TMK Energy Ltd | 0.002 | 0.001 | 100.00% | 652,609 | 3 |
KFMO | Kingfisher Mining Limited | 0.002 | 0.001 | 100.00% | 111,000 | 2 |
ICGOF | Inca Minerals Limited | 0.002 | 0.001 | 100.00% | 8,077,691 | 14 |
RR1OA | Reach Resources Ltd | 0.012 | 0.005 | 71.43% | 4,610,868 | 50 |
8VI | 8VI Holdings Limited | 0.20 | 0.08 | 66.67% | 79,733 | 34 |
BASO | Bass Oil Limited | 0.003 | 0.001 | 50.00% | 1,000,000 | 3 |
NRZO | NeuRizer Ltd | 0.003 | 0.001 | 50.00% | 1,500,000 | 3 |
ADS | Adslot Ltd | 0.0015 | 0.0005 | 50.00% | 423,530 | 1 |
TVNO | Tivan Ltd | 0.023 | 0.007 | 43.75% | 390,000 | 11 |
RR1 | Reach Resources Lld | 0.017 | 0.005 | 41.67% | 38,803,703 | 496 |
Avidity plans to accelerate the initiation of registrational cohorts in FORTITUDE™ trial Delpacibart braxlosiran (AOC 1020), the first investigational therapy to target the underlying cause of FSHD, provided greater than 50% mean reduction across multiple DUX4 regulated gene panels (2 mg/kg at four months) Trends of functional improvement including muscle strength, reachable workspace, and positive trends in patient and clinician reported outcomes demonstrated in people treated with delpacibart braxlosiran 2 mg/kg at four months Delpacibart braxlosiran data demonstrate favorable safety and tolerability with all adverse events mild or moderate Volume 9 of virtual investor and analyst series today, Wednesday, June 12 at 8:00 ...
HOUSTON, June 10, 2024 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP"), Huddled Masses LLC ("Huddled Masses") and Orange 142 ("Orange 142"), today announced the appointment of BDO USA, P.C. ("BDO") as the Company's new independent registered public accounting firm, effective June 10, 2024. BDO, one of the world's top five accounting firms, delivers assurance, tax, and advisory services to clients throughout the U.S. and around the globe. The firm is home to over 12,000 professionals spread across ...
(NASDAQ: RDFN) — More than three in five (61.9%) homes that were on the market in May had been listed for at least 30 days without going under contract, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. That’s up from 60% one year earlier and roughly 50% two years earlier.
MENLO PARK, Calif., June 12, 2024 /PRNewswire/ -- Cyngn Inc. (Nasdaq: CYN) has announced progress of its proprietary computer vision (CV) technology for industrial autonomous machines, built on NVIDIA accelerated computing. This announcement showcases the cutting-edge capabilities of Cyngn's DriveMod solutions, highlighting how NVIDIA hardware and CUDA acceleration libraries have enabled Cyngn to develop differentiated self-driving features with artificial intelligence (AI), CV, and localization and mapping.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 69,752.92 | 2,425.90 | 3.60% | 1.37T | 3,959,841,063 |
ETH | Ethereum | 3,630.12 | 132.36 | 3.78% | 435.8B | 2,346,966,030 |
BNB | Binance Coin | 630.12 | 27.67 | 4.59% | 99.36B | 329,541,481 |
USDT | Tether USD | 1.00 | 0.00012 | 0.01% | 97.84B | 242,444,969 |
SOL | Solana | 160.00 | 10.58 | 7.08% | 70.32B | 1,015,592,207 |
STETH | stETH | 3,619.65 | 122.24 | 3.50% | 35.5B | 9,254,135 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 883,435,612 |
XRP | Ripple | 0.4945 | 0.0142 | 2.96% | 26.96B | 288,289,603 |
TONCOIN | Wrapped TON Coin | 7.26 | 0.322547 | 4.65% | 25.1B | 98,369,437 |
DOGE | Dogecoin | 0.14907 | 0.01095 | 7.93% | 21.11B | 296,784,770 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions